IL2 and cancer: The ability of IL-2 to modulate these populations has led to its clinical use to treat cancer, by expanding NK cell and CD8 T cell populations within patients3,4, and to treat autoimmune conditions, largely by expanding FoxP3+ CD4+ regulatory T cells (Tregs)5.